July 29th 2025
Smart technology, personalized medicine, and the customization of CDMO relationships are helping manufacturers meet shifts in client demand.
How to Evaluate the Cost Impact of Using Disposables in Biomanufacturing
June 1st 2008The current focus on cost-of-goods (COGS) models is underplaying the benefits of disposables technology in biopharmaceutical manufacturing. The best method for accounting for the benefits of reduced and delayed capital expenditures is through the use of NPV analysis.